United Drug shares hit all-time high following earnings report
Shares in United Drug will continue their ascent after hitting a new all-time high, Dublin analysts have predicted.
The shares hit €3.48 in trading on Friday, representing a rise of 51 per cent from the start of the year.
The new peak came last week after the company reported full-year earnings, which showed double-digit growth in both turnover and net profits. The earnings were driven by increased sales in both its wholesale and distribution businesses.
“The stock is at a premium to its peer group in Europe,” said Jack Gorman, senior ...
